PeptideDB

GSK2593074A 1337531-06-2

GSK2593074A 1337531-06-2

CAS No.: 1337531-06-2

GSK2593074A (also known as GSK’074) is a novel and potent necroptosis inhibitor with dual targeting ability to both RIP
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

GSK2593074A (also known as GSK’074) is a novel and potent necroptosis inhibitor with dual targeting ability to both RIP1 and RIP3. GSK2593074A showed structural similarities to the well-known RIP3 inhibitor GSK'843. GSK'074 inhibited necroptosis with an IC50 of less than 3 nM in a variety of cell types, including mouse SMCs, fibroblasts (L929), bone marrow derived macrophages (BMDM), and human colon epithelial cells (HT29). Additionally, GSK'074 but not Nec-1s prevented SMC cytokine production. The biological targets of GSK'074 were determined by biochemical analyses to be RIP1 and RIP3. GSK'074 demonstrated no detectable cytotoxicity even at 20 µM, in contrast to GSK'843, which induces profound apoptosis at high doses (>3 µM).



Physicochemical Properties


Molecular Formula C27H23N5OS
Molecular Weight 465.569423913956
Exact Mass 465.162
CAS # 1337531-06-2
Related CAS # 1337531-06-2
PubChem CID 53466951
Appearance Light yellow to khaki solid
LogP 4.1
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 4
Heavy Atom Count 34
Complexity 732
Defined Atom Stereocenter Count 0
InChi Key LIGGMBSSOOVGAE-UHFFFAOYSA-N
InChi Code

InChI=1S/C27H23N5OS/c1-31-15-20(13-30-31)21-14-29-27(28)25-22(16-34-26(21)25)18-7-8-23-19(12-18)9-10-32(23)24(33)11-17-5-3-2-4-6-17/h2-8,12-16H,9-11H2,1H3,(H2,28,29)
Chemical Name

1-[5-[4-amino-7-(1-methylpyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]-2,3-dihydroindol-1-yl]-2-phenylethanone
Synonyms

GSK2593074A; GSK'074; GSK-2593074A; GSK 074; GSK 2593074A; GSK-074
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets RIP1; RIP3
ln Vitro GSK2593074A (GSK'074; 0.01, 0.1, 1, 10, and 100 nM; 6 hours for MOVAS cells; 3 hours for L929 cells) completely prevents necroptosis in both human and murine cells at an IC50 of ~3 nM. GSK2593074A inhibits necroptosis with an IC50 of ~3 nM in a variety of cell types, including mouse SMCs, fibroblasts (L929), bone marrow-derived macrophages (BMDM), and human colon epithelial cells (HT29)[1].
ln Vivo GSK2593074A (GSK’074; 0.93 mg/kg/day; i.p. injection; 14 or 28 days) is administrated to Apoe-/- mice immediately following pump implantation. GSK2593074A-treated mice exhibit significantly lessened aneurysm formation when compared to the DMSO group, as evidenced by a significantly smaller aortic dilatation (DMSO 85.39±15.76% vs GSK2593074A 36.28±5.76%; P<0.05) and a decreased incidence of abdominal aortic aneurysm (AAA) (from 83.3 to 16.7%). GSK2593074A significantly reduces the amount of aortic expansion (DMSO 66.06±9.17% vs GSK2593074A 27.36±8.25%; P<0.05)[1].
References

[1]. Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models. Cell Death Dis. 2019 Mar 6;10(3):226.


Solubility Data


Solubility (In Vitro) DMSO: 41.7 mg/mL (~89.5 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (4.47 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1479 mL 10.7395 mL 21.4790 mL
5 mM 0.4296 mL 2.1479 mL 4.2958 mL
10 mM 0.2148 mL 1.0740 mL 2.1479 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.